| View |
|
DRP-15266
|
Hydrocortisone (as sodium succinate)
|
Dasocort
|
100 mg
|
Powder for IM/IV Injection
|
Corticosteroid
|
Indasi Lifesciences Pvt. Ltd.
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15276
|
Esomeprazole (as sodium)
|
Esomax-WFI
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15265
|
Levodropropizine.
|
None
|
30 mg/5 mL (6 mg/mL)
|
Syrup
|
Cough Suppressant
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15274
|
Docetaxel (as trihydrate)
|
Taxelido
|
20 mg/mL
|
Solution for IV Infusion
|
Antineoplastic Agent
|
PT. CKD Otto Pharmaceuticals
|
Indonesia
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15272
|
Docetaxel (as trihydrate)
|
Taxelido
|
20 mg/mL (80 mg/4mL)
|
Solution for IV infusion.
|
Antineoplastic Agent
|
PT. CKD Otto Pharmaceuticals
|
Indonesia
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15268
|
Propofol
|
Brofol
|
10 mg/mL (200 mg / 20 mL)
|
Emulsion for IV Infusion.
|
General Anesthetic
|
Guangdong Jiabo Pharmaceutical Co., Ltd.
|
China
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15267
|
Rosuvastatin (as calcium)
|
Rosin 40
|
40 mg
|
Film-coated Tablet
|
Lipid Modifying Agent (HMG CoA reductase inhibitor)
|
SunGlow Lifesciences Private Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15273
|
Clobetasol propionate
|
Clovate
|
500 mcg/g (0.05% w/w)
|
Topical Ointment
|
Corticosteroid
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15277
|
Docetaxel
|
Olletaxel-10
|
10 mg/mL
|
Concentrate Solution for Injection
(IV Infusion)
|
Antineoplastic Agent (Taxane)
|
Bruck Pharma Private Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15278
|
Docetaxel
|
Olletaxel-40
|
40 mg/mL (120 mg/3 mL)
|
Concentrate Solution for
Injection (IV Infusion)
|
Antineoplastic Agent (Taxane)
|
Bruck Pharma Private Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15286
|
Pravastatin Sodium
|
Pravastal
|
20 mg
|
Tablet
|
HMG CoA Reductase Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
06 June 2024
|
06 June 2029
|
| View |
|
DRP-15269
|
Sterile Water For Injection
|
Sterilmed 5
|
5 mL
|
Solution For Injection
|
Diluent/Solvent for Parenteral Preparation
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15270
|
Sterile Water for Injection.
|
Sterilmed 10
|
10 mL
|
Solution for Injection.
|
Diluent/Solvent for Parenteral Preparation
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15264
|
Clobetasol Propionate.
|
Clovate
|
0.5 mg/g (0.05% w/w)
|
Cream
|
Corticosteroid
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15287
|
Irbesartan Hydrochlorothiazide
|
Berzide 25
|
300 mg/25 mg
|
Tablet
|
Angiotensin
II Receptor Blocker-Diuretic Combination
|
Healer's Lab (Unit II)
|
India
|
Initial
|
06 June 2024
|
06 June 2029
|
| View |
|
DR-XY49106
|
Levetiracetam
|
Levetroy
|
100 mg/mL
|
Concentrate Solution for Injection
(IV Infusion)
|
Antiepileptic
|
Troikaa Pharmaceuticals Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15284
|
Valsartan Amlodipine (as besilate)
|
Rovalpin
|
160 mg/ 10 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium
Channel Blocker
|
Humanis Sağlik Anonim Şirketi
|
Turkey
|
Initial
|
06 June 2024
|
06 June 2029
|
| View |
|
DRP-15285
|
Valsartan + Amlodipine (as besilate)
|
Rovalpin
|
160 mg/ 5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium
Channel Blocker
|
Humanis Sağlik Anonim Şirketi
|
Turkey
|
Initial
|
06 June 2024
|
06 June 2029
|
| View |
|
DRHR-2318
|
Isopropyl Alcohol
|
Land and Harper
|
70 mL/100 mL (70% v/v)
|
Solution
|
Antiseptic/Disinfectant
|
Jovash International, Inc.
|
Philippines
|
Initial
|
06 June 2024
|
06 June 2029
|
| View |
|
DRHR-2364
|
Methyl Salicylate + Menthol + Camphor
|
Katinko
|
140 mg / 70 mg 10 mg per g
|
Gel
|
Counterirritant
|
Greenstone Pharmaceutical, Inc.
|
Philippines
|
Initial
|
07 June 2024
|
07 June 2029
|